Featured News

The Celiac Disease Foundation is proud to share that for the second year in a row, access to funding for celiac disease research is being made available through the U.S. DOD Congressionally Directed Medical Research Programs (DOD-CDMRP)Peer Review Medical Research Program.

The Celiac Disease Foundation has joined forces with the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Foundation to introduce two groundbreaking awards specifically designed to advance celiac disease research. These initiatives aim to foster novel research endeavors, emphasizing the importance for medical professionals to delve into the complexities of this lifelong autoimmune condition. 

The Celiac Disease Foundation today announced its Board of Directors re-appointments for 2024. The Board represents a diverse mix of professionals, patients, and caregivers who are deeply committed to advancing the Foundation’s mission of accelerating diagnosis, treatments, and a cure for celiac disease.  

The Celiac Disease Foundation is expanding its operations with the appointment of three senior-level staff. These roles are aligned with the Foundation’s latest strategic plan and ongoing work to accelerate diagnosis, treatments, and a cure for celiac disease – one of the world’s most prevalent genetic autoimmune diseases.

The SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference. 

The Celiac Disease Foundation, the nation’s leading patient advocacy organization for celiac disease, today is proud to announce its newest Board of Directors appointee, Dan Gibbons, who joins the organization this month.

The Cribsiders Podcast on pediatric medicine recently released an episode with a special guest, Dr. Dale Lee from Seattle Children's Hospital, about the diagnosis and management of celiac disease.

The Celiac Disease Foundation, is proud to announce a recent grant of $200,000 from the Foster Family Foundation, which CDF will use to further its mission.

The Celiac Disease Foundation today announces the departure of Chief Development Officer Deborah Ceizler, who has served in key roles for more than 18 years.

Want to get involved in celiac disease research? It’s time to take action. The TEV-CeD Study is a phase 1b clinical trial testing the investigational medication TEV-53408 for the treatment of celiac disease.